Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 1, 1997, Pages 1-9

  Akiyama, K ^a   Suzuki, H ^a   Grant, P ^a   Bing, R J ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Myocardial infarction; Nitrate and nitrite; Nitric oxide synthase

Indexed keywords

NITRATE; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; S METHYLISOTHIOUREA SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY SINUS; ENZYME ACTIVITY; ENZYME INDUCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; LIGATION; LUNG; MALE; NONHUMAN; OXIDATION; PLASMA; PRIORITY JOURNAL; RABBIT; VEIN;

EID: 0030892660     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.9998     Document Type: Article

References (34)

1. DE BELDER AJ, RADOMSKI MW, WHY HJF, RICHARDSON PJ, BUCKNALL CA, SALAS E, MARTIN JF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
2. BREDT DS, SNYDER SH, 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033.
3. BREDT DS, SNYDER SH, 1990. Isolation of nitric oxide synthase, a calmodulin requiring enzyme. Proc Natl Acad Sci USA 87: 682-685.
4. DUDEK RR, WILDHIRT SM, CONFORTO A, PINTO V, SUZUKI H, WINDER S, BING RJ, 1994. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun 205: 1671-1680.
5. GREEN LC, DE LUZURIAGA KR, WAGNER DA, RAND W, ISTFAN N, YOUNG VR, TANNENBAUM SR, 1981. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 78: 7764-7768.
6. HAYWOOD GA, TSAO PS, LEYEN HE, MANN MJ, KEELING PJ, TRINDADE PT, LEWIS NP, BYRNE CD, RICKENBACHER PR, BISHOPRIC NH, COOKE JP, MCKENNA WJ, FOWLER MB, 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094.
7. HEVEL JM, WHITE Z, MARLETTA MA, 1991. Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein. J Biol Chem 266: 22789-22791.
8. HIBBS JB JR, TAINTOR RR, VAVRIN Z, 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476.
9. HIBBS JB JR, TAINTOR RR, VAVRIN Z, RACHLIN EM, 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 57: 87-94.
10. LANGREHR JM, MURASE N, MARKUS PM, CAI X, NEUHAUS P, SCHRUAT W, SIMMONS RL, HOFFMAN RA, 1992. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 90: 679-683.
11. LEWIS NP, TSAO PS, RICKENBACHER PR, XUE C, JOHNS RA, HAYWOOD GA, LEYEN H, TRINDADE PT, COOKE JP, HUNT SA, BILLINGHAM ME, VALANTINE HA, FOWLER MB, 1996. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93: 720-729.
12. LOWENSTEIN CJ, HILL SL, LAFOND-WALKER A, WU J, ALLEN G, LANDAVERE M, ROSE NR, HERSKOWITZ A, 1996. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97: 1837-1843.
13. MAYER B, JOHN M, BOHME E, 1990. Purification of a calcium/calmodulin-dependent nitric oxide synthase from porcine cerebellum, cofactor-role of tetrahydrobiopterin. FEBS Lett 277: 215-219.
14. MENON NK, PATARICZA J, BINDER T, BING RJ, 1991. Reduction of biological effluents on purge and trap microreaction vessels and detection of edothelium-derived nitric oxide (Edno) by chemiluminescence. J Mol Cell Cardiol 23: 389-393.
15. MONCADA S, PALMER RMJ, HIGGS EA, 1991. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 43: 109-142.
16. NODE K, KITAKAZE M, KOSAKA H, KOMAMURA K, MINAMINO T, TADA M, INOUE M, HORI M, KAMADA T, 1995. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 211: 370-374.
17. PABLA R, CURTIS MJ, 1995. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 77: 984-992.
18. POLLOCK JS, FORSTERMANN U, MITCHELL JA, WARNER TD, SCHMIDT HHHW, NAKANE M, MURAD F, 1991. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 10480-10484.
19. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580.
20. SOUTHAN GJ, SZABO C, THIEMERMANN C, 1995. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114: 510-516.
21. STUEHR DJ, MARLETTA MA, 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopoly-saccharide. Proc Natl Acad Sci USA 82: 7738-7742.
22. STUEHR DJ, CHO HJ, KWON NS, WEISE MF, NATHAN CF, 1991. Purification and characterization of the cytoline-induced macrophage nitric oxide synthase: an FAD and FMN containing flavoptoyrin. Proc Natl Acad Sci USA 88: 7773-7777.
23. SUZUKI H, WOLF PW, AKIYAMA K, HORSTMAN D, GRANT P, CANNAVINO C, BING RJ, 1996. Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle. Proc Assoc Am Physicians 108: 173-178.
24. TERMIN A, HOFFMANN M, BING RJ, 1992. A simplified method for the determination of nitric oxide in biological solutions. Life Sci 51: 1621-1629.
25. WAGNER DA, SCHULTZ DS, DEEN WM, YOUNG VR, TANNENBAUM SR, 1983a. Metabolic fate of oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Res 43: 1921-1925.
26. WAGNER DA, YOUNG VR, TANNENBAUM SR, 1983b. Mammalian nitrate biosynthesis: incorporation of 15 NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 80: 4518-4521.
27. WENNMALM A, BENTHON G, EDLUND A, JUNGERSTEN L, JENSEN NK, LUNDIN S, WESTFELT UN, PETERSSON AS, WAAGSTEIN F, 1993. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 73: 1121-1127.
28. WILDHIRT SM, DUDEK RR, SUZUKI H, PINTO U, NARAYAN KS, BING RJ, 1995a. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction. Cardiovasc Res 29: 526-531.
29. WILDHIRT SM, SUZUKI H, DUDEK R, HORSTMAN D, BING RJ, 1995b. Improvement of cardiac performance after selective modulation of increased inducible nitric oxide synthase (iNOS) formation in myocardial infarction. J Am Coll Cardiol 27: 183A 764-765.
30. WILDHIRT SM, DUDEK RR, SUZUKI H, NARAYAN KS, WINDER S, CHOE J, BING RJ, 1995c. Expression of nitric oxide synthase isoforms after myocardial infarction in humans. Endothelium 3: 209-224.
31. WINLAW DS, SMYTHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, MACDONALD PS, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.
32. WOLF A, SAITO T, DUDEK R, BING RJ, 1991. The effect of lysophosphatidylcholine on coronary and renal circulation in the rabbit. Lipids 26: 223-226.
33. YANG X, CHOWDHURY N, CAI B, MARBOE C, SCIACCA RR, MICHLER RE, CANNON PJ, 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 94: 714-721.
34. ZEBALLOS GA, BERNSTEIN RD, THOMPSON CI, FORFIA PR, SEYEDI N, SHEN W, KAMINSKI PM, WOLIN MS, HINTZE TH, 1995. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91: 2982-2988.